NYSEARCA:MSOS
AdvisorShares Pure US Cannabis ETF News
$8.13
-0.730 (-8.24%)
At Close: May 23, 2024
4 Best ETF Areas of Q1
09:00am, Thursday, 28'th Mar 2024
Wall Street is poised to conclude the first quarter with robust gains due to a likely dovish Fed and robust economic as well as earnings growth.
ETF Themes That Dominated in Q1 2023
05:41pm, Monday, 25'th Mar 2024
As the first quarter comes to a close, clearly, there have been some thematic winners in terms of flows and investment performance. Artificial Intelligence AI-themed ETFs remain among the top recipien
Is Rescheduling a Certainty for Cannabis? ETFs That Surge
09:36am, Friday, 22'nd Mar 2024
In a White House meeting, Vice President Kamala Harris this week urged the DEA to expedite the rescheduling of marijuana, criticizing its current Schedule 1 classification as "absurd" and "patently un
Investors push a Japanese ETF to fresh highs, seeking protection from a falling yen
06:22pm, Thursday, 21'st Mar 2024
Hello! This is MarketWatch reporter Isabel Wang bringing you this week's ETF Wrap. In this week's edition, we look at one of the currency-hedged Japan ETFs, which reached its all-time high on Thursday
5 Best ETF Areas of Last Week
09:01am, Tuesday, 19'th Mar 2024
Wall Street delivered a downbeat performance last week.
Cannabis ETFs Jump on Imminent Rescheduling News
11:01am, Monday, 18'th Mar 2024
Cannabis stocks & ETFs jumped on Mar 15 after a prominent hedge fund manager suggested that regulators will soon reclassify marijuana as a less dangerous drug.
Cannabis stocks rise after President Biden mentions plant in State of the Union speech
03:22pm, Friday, 08'th Mar 2024
Shares of both U.S. and Canadian cannabis stocks moved up on Friday after President Joe Biden mentioned the federal government's current effort to potentially reclassify the plant under federal law in
Marijuana ETFs Breezing Past S&P 500: More Growth Ahead?
09:41am, Thursday, 29'th Feb 2024
Cannabis stocks soared this year after the Department of Health and Human Services asked the US Drug Enforcement Administration to start reviewing its classification of cannabis from Schedule I to Sch
This Cannabis ETF Is Already Up Nearly 40% in 2024: Is Now the Time to Load Up on Pot Stocks?
10:14am, Saturday, 17'th Feb 2024
Cannabis stocks have been soaring to start the year. According to analysts, the global pot market could rise by a compound annual growth rate of more than 34% until the end of the decade.
Why high-yield bond ETFs may deliver ‘surprise' outperformance in fixed income in 2024
05:49pm, Thursday, 15'th Feb 2024
Hello! For this week's ETF Wrap, I caught up with Michael Arone, State Street's chief investment strategist, at the Exchange ETF conference in Miami. He shared his take on bonds as ETF investors look
Understanding Cannabis ETFs' Wacky Divergence
09:43am, Thursday, 08'th Feb 2024
One of the top-performing thematic segments this year is cannabis. A major catalyst has been the proposed descheduling of it from a Schedule I to a Schedule III drug under the Controlled Substances Ac
MSOS: One Of The Most Promising Setups For Cannabis Stocks In Years
03:15pm, Wednesday, 07'th Feb 2024
The US cannabis ETF MSOS is up 50% YTD, with cannabis being one of the hottest sectors in the market today. MSOS is an NYSE-traded ETF that offers investors a convenient and liquid way to invest in a
Cannabis stocks see fifth straight week of gains ahead of earnings
11:50am, Monday, 05'th Feb 2024
Cannabis stocks on Friday booked their fifth-straight week of positive returns led by the Advisorshares Pure US Cannabis ETF (MSOS) which gained 12% to finish the week at about $10.30. The Advisorshar
MSOS: Investors Should Exit This ETF
11:30am, Sunday, 04'th Feb 2024
AdvisorShares Pure US Cannabis ETF has experienced significant volatility, but has seen a recent increase in value due to potential cannabis rescheduling. The ETF is poorly diversified, with the top t
Cannabis ETFs Outperform in January
01:01pm, Wednesday, 31'st Jan 2024
The cannabis industry has been performing well this year after the US Drug Enforcement Administration started reviewing the potential reclassification of cannabis from Schedule I to Schedule III.